Evidence map›Paper›PMID 36781432›Full record

ArticleArchives of toxicology2023

A continuous in silico learning strategy to identify safety liabilities in compounds used in the leather and textile industry.

Eric March-Vila, Giacomo Ferretti, Emma Terricabras, Inés Ardao, José Manuel Brea, María José Varela, Álvaro Arana, Juan Andrés Rubiolo, Ferran Sanz, María Isabel Loza and 3 more

Full text read
In one paragraph

Article in Archives of toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Eric March-VilaDepartment of Medicine and Life Sciences, Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.
Giacomo FerrettiDepartment of Medicine and Life Sciences, Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.
Emma TerricabrasDepartment of Medicine and Life Sciences, Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.
Inés ArdaoDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, Innopharma Drug Screening and Pharmacogenomics Platform. BioFarma Research Group. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.
José Manuel BreaDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, Innopharma Drug Screening and Pharmacogenomics Platform. BioFarma Research Group. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.
María José VarelaDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, Innopharma Drug Screening and Pharmacogenomics Platform. BioFarma Research Group. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.
Álvaro AranaDepartment of Zoology, Genetics and Physical Anthropology, Universidad de Santiago de Compostela, Campus de Lugo, 27002, Lugo, Spain.
Juan Andrés RubioloDepartment of Zoology, Genetics and Physical Anthropology, Universidad de Santiago de Compostela, Campus de Lugo, 27002, Lugo, Spain.
Ferran SanzDepartment of Medicine and Life Sciences, Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.
María Isabel LozaDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, Innopharma Drug Screening and Pharmacogenomics Platform. BioFarma Research Group. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.
Laura SánchezDepartment of Zoology, Genetics and Physical Anthropology, Universidad de Santiago de Compostela, Campus de Lugo, 27002, Lugo, Spain.
Héctor AlonsoDepartment of Sustainability, INDITEX, Av. da Deputación, 15412, Arteixo, Spain.
Manuel PastorDepartment of Medicine and Life Sciences, Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain. manuel.pastor@upf.edu.ORCID 0000-0001-8850-1341

Funding

HORIZON EUROPE Framework Programme 964537
6 · The paper itself

Abstract

There is a widely recognized need to reduce human activity's impact on the environment. Many industries of the leather and textile sector (LTI), being aware of producing a significant amount of residues (Keßler et al. 2021; Liu et al. 2021), are adopting measures to reduce the impact of their processes on the environment, starting with a more comprehensive characterization of the chemical risk associated with the substances commonly used in LTI. The present work contributes to these efforts by compiling and toxicologically annotating the substances used in LTI, supporting a continuous learning strategy for characterizing their chemical safety. This strategy combines data collection from public sources, experimental methods and in silico predictions for characterizing four different endpoints: CMR, ED, PBT, and vPvB. We present the results of a prospective validation exercise in which we confirm that in silico methods can produce reasonably good hazard estimations and fill knowledge gaps in the LTI chemical space. The proposed protocol can speed the process and optimize the use of resources including the lives of experimental animals, contributing to identifying potentially harmful substances and their possible replacement by safer alternatives, thus reducing the environmental footprint and impact on human health.

Indexed as

Chemical SafetyTextile IndustryAnimalsHumansIndustryComputational toxicologyIn silicoLeather and textile industryMachine learningQSARRead across

Identifiers

PMID36781432
PMCPMC10025185

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read93
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.